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A Case of Failed Spinal in an Infant with Cystic Fibrosis and Respiratory Failure 
 
Stanlies D’Souza MD 
Department of Anesthesiology at Baystate Medical Center/University of Massachusetts Medical School 
Introduction  
We describe a case of failed spinal 
anesthesia in a neonate after satisfactory 
successful spinal  local anesthetic 
administration.  We describe the risk 
factors for failed spinal anesthesia.  
Concerns about repeat spinal are also 
addressed. 
Case description  
A 4 month old, 4.4 kg female child, with 
cystic fibrosis and failure to thrive 
secondary to pancreatic insufficiency 
presented for laparoscopic assisted gastric 
tube placement. Her past medical history 
was significant for recurrent bronchiolitis 
with acute  respiratory failure.  
 
After induction of general anesthesia 
(GA), an  intravenous line was obtained 
and spinal anesthetic was performed at 
L5-S1 level with 1mg/kg of hyperbaric 
bupivacaine. Patient was awakened and 
there was no block even after 20 min 
period.  
 
A second spinal injection was 
administered at L4-L5 level. Second spinal 
was unsuccessful.  
 
Surgery was successfully completed under 
GA and perioperative course was 
uneventful. 
Case discussion  
 
Neonatal  spinal  compared  to  adult spinal: 
 Need larger dose  due to large volume of cerebrospinal  fluid (CSF) compared to adult 
 Short duration of action  due to rapid  turnover of the CSF  
 Spinal cord ends at a lower level compared to an adult.  Spinal cord ends at the lower 
border of L1 in adults; in a newborn it ends at L3 level.  
 
 Dose of Neonatal spinal: 1 mg/kg of bupivacaine.  Inguinal hernia repair is the most  
common operation performed under spinal anesthesia in a neonate. 
Causes for failure of spinal anesthesia 1,2 
Unsuccessful lumbar puncture due to poor patient positioning or anatomical variability 
Inadequate dosage 
Loss of injectate 
Misplaced injectate due movement of needle during injection 
Inadequate intrathecal spread of successfully injected local anesthetic solution due to  
anatomical  variability 
Physiochemical incompatibility of adjunct solution   
due to alteration of pH (addition of vasoconstrictor solution) 
Local anesthetic resistance due to mutation of the sodium channel 
Repeating the spinal block 1, 2 
Confirm the complete failure of the spinal block and wait for 20 min 
before attempting a repeat spinal. In the event of patchy block or block 
with inadequate height, repeat spinal anesthetic block can result in high 
block and total  spinal  anesthesia. Total spinal anesthesia  can result in 
respiratory and cardiovascular compromise. 
Risk factors for Neurotoxicity following neuraxial blockade 
1. Preexisting neuropathy 
2. Spinal  stenosis 
3. Spinal  cord compression due to disc herniation 
4. Multiple  attempts  at  spinal leading to spinal  hematoma 
5. Indwelling  spinal  micro catheters  constantly  delivering  
      local  anesthetic  solution at  a particular  nerve root 
6.   Higher  concentration of  spinal  local anesthetic  
       (0.75%  bupivacaine  compared  to 0.5% Bupivacaine) 3 
 7.  Addition of vasoconstrictors 3 
Conclusion 
In our case  we did a repeat spinal  due  to patient’s respiratory  
condition  which  also did not work due to unknown reason.  
 
In the absence of above  known  risk factors, spinal  neurotoxicity is an 
unlikely event.  
 
The concern of such repeat spinal is  a high block, not neurotoxicity.  
References: 
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Management of failed spinal 1,2  
 
 
 
 
 
 
 
 
 
 
 
 
No block General anesthesia 
Repeat spinal: Wait for 20  min and confirm that 
there is no block before  attempting a repeat spinal 
Patchy block GA or intravenous  sedation  
Unilateral block Postural adjustments, sedation or GA 
Inadequate  height 
 
Postural adjustments, IV sedation , GA 
A Case of Lennox-Gastaut Syndrome in a Child with Panhypopituitarism 
 
Stanlies D’Souza MD 
 
Department of Anesthesiology at Baystate Medical Center / University of Massachusetts Medical School 
Introduction 
Lennox-Gastaut syndrome is childhood epileptic 
encephalopathy characterized by intractable seizures 
resident to antiepileptic medications.  Here we 
describe a child  with this syndrome who presented 
for gastroduodenoscopy. 
Case Description 
A 9-year-old male with Lennox-Gastaut syndrome 
with refractory seizures to antiepileptic therapy 
presented for gastroduodenoscopy for evaluation of 
gastroesophageal reflux disease. His history was 
significant for cerebral palsy, agenesis of corpus 
callosum, neurodevelopmental delay, sleep apnea, 
panhypopituitarism and cortical blindness due to 
septo-optic dysplasia. Panhypopituitarism was 
secondary to congenital absence of pituitary gland. 
Inhalation general anesthesia was induced with 
nitrous oxide, oxygen and sevoflurane and after 
securing an intravenous line, anesthesia was 
maintained with intermittent doses of propofol. Stress 
dose of hydrocortisone was intravenously 
administered prior to the procedure. Perioperative 
course was uneventful.  
Case Discussion 
 
 Lennox–Gastaut syndrome is a severe form of childhood epilepsy that 
typically begins at 3-5 years of age.1 
 Mode of inheritance: Most of the cases are sporadic with no family 
history.  
 From 3 to 30% may have a family history of epilepsy.1 
 More common in males than females.1 
 Frequency: Accounts for 4% of all childhood epilepsy.1 
 Incidence: 1; 50,000-1:100,000.1 
Clinical Features1 
 
 Epilepsy with frequent seizures 
 Childhood epileptic encephalopathy 
 Learning disability 
 Delayed development of motor milestones 
 Developmental delay 
Seizures in Lennox-Gastaut Syndrome1 
 
•   Intractable seizures resistant to medications 
•   Usually brief, sometimes prolonged 
•   Seizures occur most often during sleep 
•   About 75% of the seizures are tonic-clonic 
•   Other types of seizures include atypical absence seizures  
•   Seizures are associated with complete or partial loss of consciousness 
•   Seizure leads to confusion and lack of alertness which may be prolonged 
•   Seizures may be associated with drop attacks with sudden loss of 
muscle tone 
 
 Pathophysiology1 
 
• No specific genes are identified 
• Associated with pre-existing neurological condition. 
• May result from brain injuries occurring before or during birth 
• May be associated with cortical dysplasia 
• May  be a part of the genetic disorder tuberous sclerosis 
 
Anesthetic Considerations2 
 
1. Preoperative anxiety, child may not be cooperative for induction of 
anesthesia 
2. Administer regular pre-operative  anti-epileptic medication 
3. No specific anesthetic considerations 
4. Inhalational induction sevoflurane well tolerated 
5. Propofol total intravenous anesthesia (TIVA) is well tolerated (Propofol       
has anti-epileptic activity) 
6. Hepatic microsomal induction may need higher dose of drugs 
 
      Evidence of anesthetic management is limited to case reports. 
CONCLUSION 
 
No specific modification in anesthetic technique is needed 
and inhalational induction and maintenance of anesthesia with 
volatile anesthetic agents and nitrous oxide/air or TIVA is well 
tolerated as per case reports.2  We managed this case 
successfully with such technique uneventfully. 
 
References  
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Introduction 
This case involves  the  anesthetic 
management of a 15-year-old 
patient with thoracic aortic root 
dilatation presenting for multi-level 
spinal fusion for idiopathic scoliosis. 
The importance of perioperative 
hemodynamic monitoring and 
smooth arterial pressure 
management is emphasized in 
order to prevent aortic dissection. 
Case Description 
A patient with thoracic aortic root 
dilatation in Marfan Syndrome has 
an increased risk of perioperative 
aortic dissection, making strict 
control of blood pressure (BP) 
essential in the perioperative 
period. A 15-year-old, 92 kg male 
with Marfan Syndrome with 
thoracic aortic root dilatation 
presented for T3-L4 posterior spine 
instrumentation and fusion (PSIF). 
Preoperatively, he was started on 
losartan 50 mg, which was 
continued in the postoperative 
period. An arterial line was placed 
for close monitoring of BP in the 
intraoperative and postoperative 
period. We tightly controlled 
patient’s BP during induction, 
intubation, intraoperative period, 
extubation and postoperatively. 
A Case of Marfan Syndrome with Thoracic Aortic Root Dilatation 
 
Stanlies D’Souza MD 
 
Department of Anesthesiology at Baystate Medical Center / University of Massachusetts Medical School 
References: 1. Stuart AG, Williams A: Marfan’s syndrome and the heart. Arch Dis Child 2007; 92:351–56. 2. Hyun-Kyoung K, Kendra AKL, Musini VM: Beta-blockers in preventing 
aortic dissection in Marfan’s syndrome. Cochrane data base of system reviews 2014: CD011103. 3. Cattaneo SM, Bethea BT, Alejo DE, et al. Surgery for aortic root aneurysm in children: 
a 21-year experience in 50 patients. Ann Thorac Surg 2004; 77:168–76.  
CONCLUSION  
 
In our case of multi-level posterior spinal 
fusion  
for idiopathic scoliosis, we continued losartan 
in the perioperative period and avoided swings 
in blood pressure during critical times in the 
perioperative period. 
 
Case Discussion 
 
Cardiovascular manifestations of Marfan Syndrome1 
 
 Thoracic aortic root dilatation: Usually 
asymptomatic, frequency 60-80%, aortic 
dissection is the most common complication. 
Dissection is rare in children under the age of 10. 
 
 Pulmonary artery dilatation: Usually 
asymptomatic, frequency 75%, dissection is rare 
 
 Mitral valve prolapse, mitral regurgitation:  
Palpitations are usual symptoms, frequency 50-
70%, arrhythmias may be present 
 
 Descending aorta dilatation:  Usually 
asymptomatic, frequency 80-100%, increased risk 
of dissection in adults 
 
 Tricuspid valve prolapse: Patients most 
commonly asymptomatic, incidence is around 4% 
 
 Left ventricular dysfunction: Common presenting 
symptom is dyspnea.  Frequency is 100%, initially 
diastolic and may progress to systolic 
dysfunction. 
 
Medical therapy to prevent Progression of Aortic Root dilatation  
and Aortic Dissection1 
1. Beta blockers are the main mode of therapy2 
2.  Calcium channel blockers 
3. Angiotensin converting enzyme inhibitors 
4. Angiotensin receptor blockers 
Indication for Aortic Root Replacement Surgery in  
Thoracic Aortic Root Dilatation3 
1. Thoracic root diameter>5 cm 
2. Progressive dilatation>1 cm/year 
3.  Progressive aortic regurgitation 
Management Strategy for Patients with Marfan Syndrome with  
Thoracic Root Dilatation presenting for Major Surgery 
1. Close hemodynamic monitoring with invasive arterial line 
2. Avoid acute hemodynamic changes 
3. Continue the elective antihypertensive therapy in the perioperative period 
CASE DESCRIPTION 
A 75- year- old with left adrenal mass, hypertension and atrial fibrillation with 
elevated metanephrine and normetanephrine was diagnosed with 
pheochromocytoma. Adequate preoperative alpha blockade was established 
with oral doxazocin. General anesthesia with endotracheal tube was 
performed for laparoscopic left adrenalectomy. Perioperative blood pressure 
was closely monitored with an arterial line. Hypotension in the post-induction 
period was effectively managed with vasopressin. Hypertension during 
resection and hypotension following resection was were not encountered as 
this patient was adequately alpha- blocked preoperatively. 
A Case of Pheochromocytoma Presenting for Adrenalectomy  
 
Stanlies D’Souza MD, Nishant D’Souza 
 
Department of Anesthesiology at Baystate Medical Center / University of Massachusetts Medical School 
REFERENCES: 1. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr, and Endocrine Society: Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99:1915-42. 2. Ramakrrishna H: Pheochromocytoma resection: Current 
concepts in anesthetic management. J Anaesthesiol Clin Pharmacol 2015: 31: 317–23.  3. Goldstein DP,  Voigt MR,  Ruan D Current preoperative preparation of pheochromocytoma/ Paraganglioma Syndrome. Clinics in Surgery 2017; 2:1517.  4. Mellom MJ,  Sundaram CP: Laparoscopic Adrenalectomy for Pheochromocytoma Versus Other Surgical 
Indications . JSLS. 2008; 12: 380–38.  5. Lord MS, Augoustides JG: Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.  Cardiothoracic Vasc Anesth. 2012: 26:526-31. 
CONCLUSION  
 
Preoperatively, adequate selective alpha2 blockade with 
doxazocin minimizes hypertensive and hypotensive episodes 
during pheochromocytoma resection.3  
INTRODUCTION 
Adequate preparation with alpha 
blockade is important  in a patient 
presenting for pheochromocytoma 
resection. Use of vasopressin is 
indicated to treat intraoperative 
hypotension refractory to alpha 
agonistic agents. Clevidipine is a 
new, novel agent effective in the 
management of hypertensive 
episodes.  
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CLINICAL FEATURES: Headaches, Palpitations, Diaphoresis , Severe  Hypertension , 
Postural Hypotension, Tachyarrhythmias, Diabetes mellitus,  Pallor,  
Weight Loss, Cardiomyopathy 
PREFERRED DIAGNOSTIC TESTS 
for Pheochromocytoma (per Task 
Force of the Endocrine Society):1 
1. Plasma metanephrine: Sensitivity 96%, specificity 85% 
2. 24-hr collection of urinary catecholamines: Sensitivity 87.5%, 
specificity 99.7% 
PREOPERATIVE PREPARATION: 1. Initiate alpha blockage 10-14 days before surgery 
2. Initiate beta blockade only after complete alpha blockade 
ALPHA BLOCKERS for 
preoperative preparation:2,3 
 
1. Phenoxybenzamine:  Non-selective; prolonged half-life; causes reflex 
tachycardia; should be stopped within 24-48 hours 
2. Doxazocin:  Selective Alpha 2 antagonist; doesn’t cause reflex 
tachycardia; reduced incidence of intraop hypertension and postop 
hypotension 
PREOPERATIVE OBJECTIVES  for 
adequate  alpha  blockade:2  
 
1. Control hypertension.  2.  Reverse  circulating blood volume. 
3.  Control heart rate and arrhythmia.  4. EEG free of ST segment and T 
wave changes.  5.  Reverse hyperglycemia and electrolyte abnormalities.  
PREOPERATIVE TARGETS of 
adequate alpha blockade:2 
1. In-hospital blood pressure below 160/90 mmHg for 24 hours prior to 
surgery. 
2. No orthostatic hypotension with blood pressure <80/45 mmHg. 
3. EKG free of ST and T wave changes for one week prior to surgery. 
4. Fewer than five (5) premature ventricular contractions per minute. 
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DRUGS TO AVOID INTRAOPERATIVELY2,3 
(Laparoscopic adrenalectomy is currently the surgical method of choice) 
 Histamine releasing drugs (morphine, atracurium) 
 Vagolytic agent (pancuronium) 
 Ketamine 
CRITICAL PERIODS OF HEMODYNAMIC CHANGES DURING RESECTION2,3 
 Catecholamine surge leading to hypertensive episode:   Laryngoscopy;  
peritoneal insufflation; tumor manipulation 
 Hypotension due to catecholamine decline:  Tumor ligation 
ANESTHETIC GOALS2,3 
1.  Avoid or reduce catecholamine release due to surgical and anesthetic techniques 
2.  Avoid drugs that release catecholamines or histamines 
3.  Minimize the hypertensive response during tumor handling. 
4.  Minimize the hypotensive response following tumor resection.  
PHARMACOLOGICAL AGENTS TO CONTROL HEMODYNAMIC CHANGES 
DURING SURGERY5 
CLEVIDIPINE is effective in controlling hypertension during tumor handling. 
VASOPRESSIN is the agent of choice to treat hypotension resistant to alpha 
adrenergic agonistic agents. 
 
 
 
 
 
 
 
 
 
. 
 
 
Stanlies D’Souza, M.D.  
Department of Anesthesiology at Baystate Medical Center/University of Massachusetts Medical School 
A Case of Severe Emergence Agitation in the Postoperative Care Unit  
in a Child with Lost Intravenous Line 
Case descript ion  
Introduction 
We describe a case of management of 
emergence agitation in a nonverbal 
developmentally delayed anxious child 
without an intravenous line in the 
postoperative care unit (PACU). 
A 6 year old, morbidly obese, 77 kg male, non-
verbal with developmental delay and autism 
presented for resection of in-growing toe nail. 
He had oral midazolam preoperatively and 
was cooperative for inhalational induction 
with nitrous oxide, oxygen and sevoflurane.  
 
After securing an intravenous (IV) line after 
induction, laryngeal mask airway (LMA) was 
placed and anesthesia was maintained with 
sevoflurane, fentanyl and local digital block. 
Propofol was administered pre-emptively for 
emergence agitation at the time of removal of 
the LMA under deep anesthesia. Patient 
became combative in PACU and IV was lost.  
 
Emergence agitation was successfully 
managed with intramuscular lorazepam and 
haloperidol. 
Risk factors for  pre-op 
anxiety 1 
•  Preschool chldren 
• No siblings 
• Shy or inhibited children 
• High IQ with poor social adaptive 
abilities 
• Divorced or separated parents 
• Prior bad experience with surgical 
experience 
• Poor child-parent relationship 
Options to  manage pre-op 
anxiety  in  our  chi ld 2 
1. Parental presence at induction 
2. Oral midazolam 
3. Oral Lorazepam 
4. Oral ketamine 
5. Oral Clonidine 
6. Oral Dexmeditomidine 
Factors not  associated with  
increased  incidence  
of  emergence agi tat ion 2 
• Rapid emergence from anesthesia 
• Depth of anesthesia 
• Duration of anesthesia 
• Emergence agitation from a prior 
anesthetic 
• Type of surgery  provided pain is well 
controlled 
Prevent ion of   emergence agi tat ion 2,3 
1. Propofol 1mg/kg at the time of emergence 
2. Fentanyl  IV 
3. Dexmedetomidine IV 2 
4. Clonidine 1V 2 
5. Ketamine IV 
1.  Preoperative anxiety 
2. Preschool children 
3. Sevoflurane anesthesia 
4. Pain 
Risk factors  for  emergent  
agi tat ion 2 
Factors of  unproven benef i t  in  the 
management  of  emergence agi tat ion 2 
1. Parental presence 
2. Midazolam  
3. Dexmeditomidine PO  
Management  of  emergence del i r ium in  a  
pat ient  wi th  lost   IV  in  PACU 
1.  IM  Benzodiazepines, Lorazepam/Midazolam 
2.  IM Haloperidol 
3.  IM Dexmeditomidine 
4.  Induction of general anesthesia and insertion of  IV 
Assess  the pat ient  for  potent ia l ly  
dangerous causes of  agi tat ion in   PACU 
Hypoxia, Hypoglycemia, Pain, Hypercarbia 
Deep removal of LMA vs awake extubation of 
endotracheal tube 4  
The incidence of emergence agitation is lower when 
LMA is removed deep compared  to awake extubation 
of an endotracheal tube anesthesia. 
 
REFERENCES:  
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Case discussion 
Conclusion:  In the absence of an IV In our 
case, we successfully managed emergence 
agitation with intramuscular lorazepam 
and haloperidol. 
A Case of Severe Factor VIII Deficiency 
 
Onyinyechukwu Ochi MD, Stanlies D’Souza MD 
Department of Anesthesiology at Baystate Medical Center/University of Massachusetts Medical School 
Discussion 
Hemophilia A (factor VIII deficiency) is an X-linked coagulation factor 
disorder associated with bleeding of variable severity, from life-threatening 
to clinically silent. 1  
 
Factor VIII deficiency/Hemophilia A affects 1 in 5000 to 10,000 males; 
roughly 60 percent have severe disease, with factor VIII activity less than 
1 percent of normal.1,2 
 
The factor VIII gene is located on the X chromosome. It is one of the 
largest known genes. It  circulates in plasma with von Willebrand factor. 
Cleavage of factor VIII by thrombin or factor Xa is necessary to activate 
factor VIII and allow it to participate in the intrinsic pathway. Activated 
factor VIII is inactivated by activated protein C in conjunction with 
proteins.3,4,5 
 
In patients with hemophilia with acute bleeding, the immediate goal is to 
raise the factor activity to a level sufficient to achieve hemostasis.2 
 
For severe bleeding, the factor activity level should be maintained above 
50 percent at all times. 
  
An initial dose of  50 units/kg to raise the factor VIII level to 100 percent 
should be given. The second and subsequent doses are given at intervals 
of approximately one half-life of the infused product for that patient. A 
typical half-life for standard half-life factor VIII products is approximately 8 
to 12 hours.2,3 
 
For patients who require perioperative factor administration, the initial 
dose should be timed to provide maximal coverage at the time of greatest 
bleeding risk (or, typically, 30 to 60 minutes before the procedure). The 
dose is calculated from the patient's weight, baseline factor level, desired 
factor level, volume of distribution, and presence of an inhibitor.2,5 
REFERENCES 
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Therapies other than factor replacement 1,2,4 
Therapies Use DOSAGES 
Tranexamic Acid 
(TXA) 
Inhibit fibrinolysis by inhibiting 
plasminogen activation in the 
fibrin clot, thereby enhancing 
clot stability. 
25 mg/kg every 6-8 hours 
Epsilon  
Aminocaproic 
Acid (EACA) 
Same as above 75-100 mg/kg every 6 hours, max 3-4g 
Desmopressin 
(DDAVP) 
Increases factor VIII level two-
four fold.  Not effective for 
patients with severe 
hemophilia A (Factor VIII 
activity <1%). 
0.3 mcg/kg (max, 20 mcg/kg), IV or nasal 
Factor Replacement 
 
Purified factor products are the 1st choice and 
should be used whenever possible to avoid 
potential transfusion-transmitted infection and 
transfusion reactions.2,4 
 
However, other blood products like 
Cryoprecipitate can also be used. One bag of 
Cryoprecipitate is made from approximately 250 
mL of fresh frozen plasma (FFP) and contains 
approximately 70 to 80 units of factor VIII in a 
volume of 30 to 40 mL (approximately 3 to 5 
units/mL).2  
 
FFP is deemed an inadequate choice for factor 
replacement  because 1mL of FFP contains 1unit 
of factor activity. A dose of 15 to 20 mL/kg will 
raise the factor VIII level by approximately 30 to 40 
percent. This amounts to lots of bags of FFP to 
get the desired  factor amount, which 
consequently exposes patient to possible fluid 
overload, transfusion infections and reactions.1,2 
Introduction3,5 
Hemophilia refers to an inherited 
bleeding disorder caused by deficiency of 
coagulation factor VIII (hemophilia A), 
factor IX (hemophilia B), or factor XI 
(hemophilia C). Hemophilia A and B are 
X-linked recessive diseases that present 
in male children of carrier females.3,4 
 
Hemophilia A – Inherited deficiency of 
factor VIII; an X-linked recessive 
disorder4.  
 
                     Case description  
Patient is a 5-year-old male with severe 
factor VIII deficiency initially diagnosed, at 
age 3, as severe oral bleeding following a 
lip laceration.  His factor VIII was less 
than 1%.  Consequently, patient had been 
on "on demand" replacement but, due to 
an increase in bleeds, is being switched 
to prophylaxis.  The main joints affected 
are the elbows, knees and ankles.  
Because of the increasing need for home 
factor infusion, a Port-A-Cath is being 
placed.  His disease is considered 
severe.  The known duration is 
approximately two years and is 
associated with spontaneous 
hemarthroses and bleeding.  It is 
ameliorated with factor replacement. 
Patient is to receive Recombinant factor 
VIII 500 units IV twice a week 
(approximately 18 U/kg). 
 
Before the procedure, patient received 
approximately 50 U/kg of recombinant 
factor VIII immediately before the port 
placement. He was intubated with an 
LMA and had no excessive bleeding 
during the procedure. 
Fig. 2.  Source: Managing  Your 
Hemophilia..  Copy right  © 
2016 by Saunders, an imprint of 
Elsevier, Inc.  Downloaded from 
ClinicalKey.  Accessed Sept. 22, 
2018.  
Fig. 1. Source:  Bhat R, Cabey 
W.  Evaluation and 
Management of Congenital 
Bleeding Disorders.6 
Downloaded from Clinical 
Key.  Accessed Sept 22, 2018.  
Conclusion 
 
• Perioperative management of Factor VIII deficiency, is dependent on 
the severity of the factor deficiency as well as the type of procedure 
being performed.1,3 
• Factor VIII replacement with recombinant Factor VIII, 30 minutes 
before surgery, is the preferred method of treatment; however, 
alternative forms of replacement, factor related and otherwise, can be 
implemented.2,4 
• Depending on the surgery, factor replacement should be given before 
and after surgery, as surgeries with a lot of blood loss deplete Factor 
VIII faster.2,3,5 
A Case of Spinal Anesthesia in a Neonate 
 
Onyinyechukwu Ochi, MD and Stanlies D’Souza, MD 
Department of Anesthesiology at Baystate Medical Center/University of Massachusetts Medical School 
INTRODUCTION 
 
Spinal anesthesia in neonate is used 
primarily to reduce immediate pain 
perioperatively as well as post-
operative  apneic complications due 
to  opioid use.  
 
DISCUSSION 
 
Neuraxial agents provide full-bodied pain control, have the 
potential to improve outcomes, and are an important 
component of the perioperative care of children.2 
 
 The control of afferent traffic through neuraxial interventions 
(epidural or intrathecal delivery) can be utilized in neonates 
and infants as a sole neuraxial anesthetic technique for 
abdominal and lower limb surgery or  as a supplement to 
reduce intraoperative general anesthetic requirements and 
manage peri-operative pain.1 
 
 “Single shot” spinal anesthesia provides an alternative to 
general anesthesia for lower abdominal or inguinal surgery.3 
 
  The clinical utility of this technique is limited by the duration 
of action of intrathecal local anesthetics in neonates 
however, and conversion to general anesthesia is often 
required if surgical duration exceeds one hour.1   
 
CONCLUSION 
Neuraxial agents provide robust pain control, have the potential to improve outcomes, and are an important 
component of the perioperative care of children.1 
Neonates need a larger dose of neuraxial anesthetic due to high cerebrospinal fluid (CSF) volume and the 
duration of action is shorter due to rapid turnover of the CSF compared to an adult.  
CASE DESCRIPTION 
 
 
A 4.7 kg 6-week old male born full-
term with no prior medical history, 
presented for an incarcerated left 
inguinal hernia needing repair. In the 
quest to reduce the exposure of 
general anesthesia as well as apneic 
episodes from opioid in this neonate, 
surgical procedure under spinal 
anesthesia was implemented. 
  
Method: Patient was brought into the 
operating room (OR) and placed in 
the left lateral decubitus position on 
the OR table. Patient’s back was clean 
with chlorohexidine and draped 
afterwards. Skin infiltration with local 
anesthetic was used before the single 
spinal injection of 0.6ml of 0.75% 
bupivacaine was placed at the L5-S1 
level. Patient was then laid on his 
back and surgery ensued. The spinal 
anesthesia was adequate for the 
duration of the surgery and 
perioperative course was uneventful. 
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Fig. I. Sitting or lateral position for spinal anesthesia procedure.  
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Benefits of Using Spinal Anesthesia in 
Neonates 
 Neuraxial analgesia may improve 
postoperative outcomes for high-risk 
neonates who are susceptible to respiratory 
complications (e.g. preterm born neonates 
with lung disease and postoperative apnea).  
Less post-operative apnea from opioid use.2 
 Analysis of four trials comparing spinal and 
general anesthesia in neonates born preterm 
undergoing inguinal herniorrhaphy found a 
reduction in the incidence of postoperative apnea 
only if systemic sedatives were avoided.2 
 
 Minimize the exposure of the developing brain to 
general anesthesia 
 Exposure to general anesthesia reduces excitation 
(NMDA antagonists) or enhances inhibition (GABA 
agonists), may trigger excessive apoptosis in many 
brain areas.  
 It has been suggested that spinal anesthesia can 
reduce costs related to postoperative monitoring 
and hospitalization. 
 Attenuation of stress response. 
 Cardiac stability 
 Reduction in hospital stay 
 Improved surgical outcome 
 
Adverse effects of spinal anesthesia of the types 
commonly seen in adults—hypotension, bradycardia,  
postdural puncture and transient radicular 
symptoms—are less common in children. 2 
 
 
Fig. 2.  Spinal anesthesia procedure in sitting position in 1-month-old girl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Image Source: Dadure C, Sola C, Dalens B, Capdevila X.  Regional Anesthesia 
in Children. In: Miller’s Anesthesia, 8th edition, Chap. 92, Fig. 92-8, p.2706-
2756.e7. Downloaded from ClinicalKey.  
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Case Discussion 
 
 
Characteristics of Suboxone® (buprenorphine/naloxone)1 
 
Suboxone® is an alternate mode of pain management in the opiate dependent. As per Cochrane 
database review, It is equally as effective as methadone.2 
 
BUPRENORPHINE: 
 Partial Mu receptor agonist 
  High affinity to Mu receptor 
  1000 times more potent compared to  morphine in  its affinity to Mu receptor 
  Slowly dissociates from Mu receptors 
  Partial Kappa receptor antagonistic activity 
  1000 times more potent at Kappa receptor activity 
  1000 times more potent than morphine at Kappa receptor antagonistic activity 
  It displaces other opiate agonists such as fentanyl, hydromorphone, methadone or morphine 
 Has ceiling effect due to partial agonistic activity at Mu receptor 
  Greater safety profile in the event unintentional overdose compared to other opiates 
  Less respiratory depression compared to other opiates 
  Low potential for abuse or physical dependence  
  
NALOXONE: 
  Naloxone is added to reverse the effect of intravenous opiate abuse. 
Multimodal Pain Management Approach in Patient on Suboxone® 
  
There is no consensus about how to manage acute pain in a patient on 
Suboxone®. However, a multimodal approach should be considered for acute 
pain management in surgical patients. 
 
 Regional anesthesia: Peripheral nerve blocks or neuraxial blockade 
 High dose opiates 
 Intravenous lidocaine 
 Gabapentin or pregabalin 
 Non-steroidal anti-inflammatory drugs 
 Acetaminophen 
 Ketamine 
 Magnesium 
Pain management options in a patient on Suboxone®1 
 
 Stop Suboxone® and add full opiate agonist preoperatively 
  
 Continue Suboxone® and add high dose opiates to the pain management regimen 
  
 Continue Suboxone® and give it additionally in the perioperative  period 
 
CONCLUSION 
 
We successfully managed the pain in the perioperative period with a 
multimodal approach using high dose fentanyl, intravenous 
acetaminophen, ketorolac, magnesium, ketamine and lidocaine. 
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Introduction 
Acute surgical pain management in 
the perioperative period for 
scheduled surgical procedure is 
challenging as there are no 
consensus guidelines for 
buprenorphine/naloxone 
(Suboxone®) use in the 
perioperative period. Here we 
present management of such a 
patient who presented to surgery 
with Suboxone® use on the day of 
the surgery. 
Case Description 
A 44-year-old woman on 12 mg 
Suboxone® per day with past 
history of narcotic addiction, with 
radiculopathy secondary to C3-4 disc 
herniation, presented for anterior 
cervical discectomy and fusion. She 
received oral acetaminophen 
preoperatively. During general 
anesthetic with endotracheal 
intubation, her multimodal pain 
management plan included 
intraoperative intravenous 
administration of fentanyl, ketorolac, 
dexmedetomidine bolus followed by 
infusion, lidocaine bolus followed by 
infusion, magnesium infusion, 
ketamine and postoperative 
administration of Suboxone®. She 
was comfortable in the 
postoperative period. 
 
 
 
 
 
 
  Airway management of a patient with an anterior mediastinal mass  
with complete opacification of left hemithorax  
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Introduction 
Case description  
An anterior mediastinal mass may compress the major 
airway and may result in total compression during induction 
of anesthesia. Identification of airway compression warning 
signs preoperatively and adequate preoperative preparation 
for airway management in the event of total airway 
compression is a vital part of anesthetic technique in the 
anesthetic management of a patient with large anterior 
mediastinal mass. 
A 74 year old woman with an anterior mediastinal mass with 
total obstruction of the left main stem bronchus presented 
for flexible bronchoscopy. Her imaging studies showed a 
large lobulated mediastinal mass measuring 15 cm X 13 cm 
X 12cm with complete obstruction of left main stem 
bronchus with   opacification of left hemithorax secondary to 
atelectasis of the left lung.  An underlying pleural effusion is 
also a contributory factor for this opacification.  
 
A gentle induction of general anesthesia (GA) was 
performed  with a combination of propofol and sevoflurane, 
with patient breathing spontaneously. After confirming easy 
mask ventilation, rocuronium was administered and the 
airway was easily secured with an endotracheal tube with 
direct laryngoscopy.  
CONCLUSIONS 
Maintenance of spontaneous ventilation during induction of general anesthesia is paramount in a 
patient with airway compromise with an anterior mediastinal mass.  In our patient we were able to 
intubate while maintaining spontaneous ventilation and after confirming of adequate ventilation we 
administered non depolarizing muscle relaxant. 
 
Preoperative warning  signs:2 
• Dyspnea 
• Inability to assume supine position 
• Signs airway compromise on chest X-ray  
     and CT scan 
• Hypoxia  with supplemental oxygen 
 
 
Warning signs on CT: 
• Narrowing of trachea  or major bronchi 
• Atelectasis of whole lung / one or more lobes 
 
 
Unique preparation  for a patient with a 
large mediastinal mass with airway 
compromise:2 
• Rigid bronchoscope for high frequency ventilation 
• Thoracic surgeon standby 
• Cardiopulmonary (CPB) bypass standby 
• ECMO standby 
 
 
Possible Reasons for opacification of left  
hemithorax in our case: 
1. Atelectasis due to left main stem bronchial 
obstruction 
2. Atelectasis due to endobronchial extension 
3. Underlying pleural effusion 
 
Other considerations:2 
1. Flow volume loops show variable intrathoracic 
obstruction. CT is diagnostic and preferable over flow 
volume loops 
2. Start intravenous line in lower extremity in the presence 
of superior vena cava obstruction  
3. Initiate  ECMO or CPB cannulation under sedation prior 
to induction 
 
Airway management techniques: 
1. Awake fiberoptic intubation 
2. Inhalational induction with patient breathing 
spontaneously 
 
Specialized endotracheal tubes for airway 
management: 
1.  Reinforced endotracheal tube 
2.  Long microlaryngoscopy tubes 
3.  Double lumen tubes 
 
Airway Management  techniques  for possible 
airway compression post induction:2 
1. Pass the reinforced  endotracheal tube distal to the 
obstruction, 
2. Rigid bronchoscopy and high frequency ventilation 
3.  Endobronchial stent placement  
4. Cardiopulmonary bypass 
5.  ECMO 
 
REFERENCES:  1. Balk R, Stevens D:  Etiology and diagnosis of mediastinal masses. Hospital Physician Pulmonary Board review manual. Pulmonary disease 1999 ; 6 part 2: 1-11 
2. Gothard JWW: Anesthetic considerations with anterior mediastinal masses. Anesthesiology clinics; 2008:26:305-11 
• Anterior  Thymus, Lymph nodes and fat  
• Middle     Heart, Pericardium, Aorta, vena 
cava,  
     pulmonary vessels, lymph nodes, fat 
• Posterior   Aorta, thoracic duct nerves, 
azygos vein, hemiazygos vein, lymph 
nodes , fat 
 
 
 
 
• Boundaries:  Anteriorly by sternum,  
posteriorly by brachiocephalic vessels,   
pericardium and aorta 
• Contents : Thymus, lymph nodes and fat 
 
 
 
Benign: 
• Thymoma 
• Thymic cyst 
• Thymic hyperplasia 
• Thyroid 
• Cystic hygroma 
 
Malignant: 
• Lymphoma 
• Thymic carcinoma 
• Seminoma 
• Thyroid carcinoma 
• Metastatic lung carcinoma 
Mediastinal components1 
Anterior mediastinal masses 1, 2 
Anterior Mediastinum 1 
Case discussion 
Figure 1.  Chest X-Ray AP view.  Image of 
Baystate Medical Center patient.  
Table 1. Precautions before Anesthesia and    Anesthetic Considerations1-6 
 
Risk of Difficult Airway -Micrognathia 
-Limited temporomandibular joints mobility 
-Atlanto-occipital instability 
-Fusion of cervical vertebrae 
-Short neck 
-Craniofacial anomalies 
Difficult Venous Access and regional block -Severe flexion/contracture abnormalities of the 
extremities 
-Joints pterygia 
Abnormal cardiopulmonary function -Severe scoliosis 
-Congenital cardiomyopathy 
-Congenital hypoplastic lungs, tracheal stenosis 
Neuromuscular Disease  
Risk of hyperkalemic response to succinylcholine 
Risk of aspiration 
-Muscle atrophy 
-Absence of muscles 
-Muscle structural abnormalities 
Risk of hyperthermia -Hypermetabolism 
 
  
Hall, J. Arthrogryposis (multiple congenital contractures): Diagnostic approach to etiology, classification, 
genetics, and  general principles.  European  Journal  of  Medical  Genetics. July 2014 . Image obtained from 
Clinical key. 
Figure 1:  Mechanism of Secondary Effects of Fetal Akinesia5   
Hall, J. et al. Emery and Rimoin’s Principles and 
Practice of Medical Genetics. Arthrogryposes 
(Multiple Congenital Contractures). Figure 161-2. 
Jan 2013. Image obtained  from Clinical  Key.   
Figure 2.  Distal Arthrogryposis Type I6 
Note predominant  distal contractures, with 
overlapping  finger contractures, ulnar 
deviation, and clubfeet.   
Arthrogryposis is a spectrum of 
disorders characterized by persistent 
multiple limb contractures. It is often 
associated with myopathies, spinal 
muscular atrophy, and hypotonia.  
 
Due to the abnormal craniofacial 
features along with severe limb and 
neck contractures, patients with 
Arthrogryposis syndromes often 
present with difficult airway 
management, intravenous (IV) line 
placement, neuraxial technique and 
patient positioning. 
INTRODUCTION  
A 9-year-old female with history of 
congenital bilateral talipes 
equinovarus with underlying 
Arthrogryposis syndrome status post 
triple arthrodesis presented for 
bilateral cast removal and short leg 
cast application.  
 
The patient received inhalation 
masked induction with sevoflurane 
and nitrous oxide. A Laryngeal Mask 
Airway (LMA) was placed after 
successful placement of left hand 
peripheral IV. General anesthesia 
was maintained with sevoflurane 
inhalation. Patient's temperature 
was monitored closely during the 
intraoperative period.  
 
Her perioperative course was 
uneventful and patient was 
discharged home same day of 
surgery. 
CASE DESCRIPTION  
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Patients with Arthrogryposis syndromes are at increased risk of difficult airway management, challenging 
vascular access, and hypermetabolic state with hyperthermia in the setting of myopathies. Along with 
joint contracture problems and associated congenital anomalies (cardiac, respiratory, genitourinary, 
neurogenic, and facial anomalies) present further challenges for anesthesiologists.  
Therefore, careful airway evaluation, close perioperative monitoring of vitals for hyperthermia, 
tachycardia, and hypercarbia, and preparation for anticipated emergencies are needed to avoid critical 
events. 
CONCLUSION  
Most  Arthrogryposis Syndrome cases are of sporadic inheritance.  
Incidence varies from 0.3-3 cases per 1000  live  births.1  
• Arthrogryposis Multiplex Congenita (AMC), most severe arthrogryposis syndrome, are characterized 
by multiple joint contractures with coexisting comorbid multisystem disease such as pharyngeal, 
cardiac, urologic, and gastric abnormalities.2  
• The less severe, Distal Arthrogryposis Syndromes (DAS) only involve distal joints such as hands and 
feet. Neurologic development is normal and response to physical therapy is usually good in patients 
with DAS.  
 
Clinical diagnosis is usually made at birth. Severe equinovarus deformity of the feet usually presents. 
The face is usually round, flat nasal bridge, and micrognathia. Contractures and rigidity of the joints are 
common and result in joint pterygia and dislocation of large joints (hip, knee, shoulder and elbow). There 
is significant decrease mobility of temporomandibular joint, atlantoaxial instability, scoliosis, and/or 
fusions of cervical vertebrae have been reported.1  
 
Abnormal craniofacial features along with severe limb and neck contractures result in difficult airway 
management, therefore spontaneous ventilation is recommended until the airway is secured. The use of 
LMAs, fiberoptic intubation, or fiberoptic-guided intubation via LMAs have been proposed and used 
successfully. Careful intraoperative positioning is mandatory to prevent injuries and fractures. Risk of 
hypermetabolism and hyperpyrexia during and after anesthesia has been described in prior case reports. 
However, no relation between malignant hyperthermia and arthrogryposis has been demonstrated.1-3  An 
exaggerated hyperkalemic response to succinylcholine may occur secondary to muscle structure 
changes.  
DISCUSSION  
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      Table 2: Extracerebral  Anomalies1,2 
 Cleft palate  Congenital heart defects (VSD) 
 Micrognathia  Renal abnormalities 
 Eye abnormalities (increased intraocular 
pressure) 
 Infundibular hematomas 
 Skeletal abnormalities (lumbar vertebrae)  Posterior fossa lymphomas 
 Polydactyly   Syringomyelia 
              Table 1: Clinical Aspects of Dandy Walker Syndrome1,2 
    Obstructive Hydrocephalus • Cranial nerve palsies 
    Raised intracranial pressure • Irritability 
• Vomiting     
• Convulsions 
    Cerebellar signs • Ataxia 
• Nystagmus 
    Agenesis  of Corpus  Callosum • Developmental delay/Mental retardation 
• Medullary failure (respiratory regulation) 
     Seizures  
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Dandy-Walker Malformations are often associated with craniofacial abnormalities, elevated ICP, post-
operative respiratory complications that could cause challenges in anesthetic management 
 
Key to successful anesthetic management in these patients are careful assessment of airway anatomy 
with appropriate plan for difficult airway, ICP control and attentive post-operative care monitoring.  
CONCLUSION  
Dandy-Walker Malformation is a heterogeneous and in some cases auto recessive inheritance. Incidence 
of 1:25,000 newborns.1 Affected children with hydrocephalus often present with bulging fontanelles and 
occiput, congenital neurodevelopmental and craniofacial anomalies.1,2 Therefore, patients with DWM often 
can present with potential challenging airway management requiring advance airway equipment 
preparation at bedside, such as rigid or flexible fiberoptic airway equipment. 
 
A major concern in a patient with DWM is intracranial pressure (ICP) management. Endotracheal 
intubation should be done as gentle as possible. An LMA was used in our case to avoid increased 
sympathetic response from intubation. The use of succinylcholine is also often avoided as it has the 
potential to increase ICP. Inhalational agents cause a dose dependent rise in ICP, however isoflurane and 
sevoflurane  <1 MAC concentration do not cause a significant rise in ICP. In addition, hypercarbia results in 
an increase in cerebral flow and as a result elevates ICP.2-5 End tidal CO2 should be maintained at 30-
35mmhg. 
 
 
In addition to the 4th ventricle and cerebellum abnormalities, agenesis of Corpus Callosum in DWM 
patients increases their likelihood of apnea and respiratory failure.4 Confirm adequate oxygenation and 
ventilation prior to extubation. Precautions must be taken for post-operative respiratory decompensation.  
                                       DISCUSSION  
A 10-year-old female with bilateral 
congenital talipes equinovarus and 
developmental delay secondary to 
underlying DWM who had shunted 
hydrocephalus in infancy presented for 
left foot osteotomy, calcaneocuboid 
fusion, and heel cord lengthening for 
recurrent left foot deformity.  
 
After inhalational induction and placement 
of an intravenous line, airway was 
managed with a laryngeal mask airway 
(LMA). The perioperative course was 
uneventful. 
CASE DESCRIPTION  
Dandy-Walker Malformation (DWM) is a 
congenital anomaly of the cerebellum and 
fourth ventricle characterized by 
hypoplasia of the cerebellum and 
hydrocephalus secondary to cystic 
expansion within the fourth ventricle. 
 
Such malformations commonly result in 
increased intracranial pressure from 
hydrocephalus and facial anatomical 
distortions such as cleft lip/palate, 
hyperterlorism and micrognathia making 
airway management challenging.  
INTRODUCTION  
Figure 1. Dandy-Walker Malformation with Enlargement of Posterior Fossa.  
A)T2 Weighted MRI. Absence of cerebellar vermis (arrow).  
B) T1 weighted MRI. Elevation tentorium (bottom arrow)  and Hydrocephalus.7  
Image  obtained from Clinical  Key  
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CONCLUSION 
  
Dexmedetomidine-induced fever is a rare side effect that clinicians should be 
aware of, especially in the ICU setting, where it is a common choice for 
sedation. Since there are so few documented cases and the fever can 
manifest at varying time intervals2, dexmedetomidine fever should be 
considered in the differential diagnosis for fever for any patient receiving it for 
sedation.  One possible explanation for the mechanism of fever is via direct 
stimulation of areas of the brain responsible for thermoregulation, such as the 
Caudal Raphe Magnus by the Locus Coeruleus.1  The Locus Coeruleus, as  
the primary site of action of Dexmedetomidine, is implicated in many 
important physiologic functions, although why some patients develop fever 
and others do not is not understood.2  Diagnosis of dexmedetomidine-
induced drug fever should be treated immediately, since body temperature 
can become severely elevated.  As with other cases of drug fever, the 
offending agent should be discontinued and active cooling measures  
initiated.  IV acetaminophen and cooling blankets can be employed and other 
causes of fever must be considered since dexmedetomidine-induced fever is 
a diagnosis of exclusion.  
INTRODUCTION 
 
I am pleased to present a case highlighting a rare complication of dexmedetomidine and 
describing: (1). Its relationship to the administration of dexmedetomidine; (2). A possible 
mechanism for dexmedetomidine-induced fever; and (3). Management of 
dexmedetomidine-induced fever in a critical care setting.  
 
 
CASE HISTORY 
 
A 79-year-old male with incarcerated umbilical hernia, afebrile and on broad spectrum 
antibiotics, underwent a right hemicolectomy for incarcerated inguinal hernia. Following 
uneventful surgery, the patient was transferred to ICU for postoperative management.  
Intravenous dexmedetomidine infusion (1mg/kg bolus followed by 0.4 mcg/kg/hr) was 
started for postoperative agitation.  However, shortly after starting the infusion, the patient 
became febrile to 105.8° by esophageal temperature.  Dexmedetomidine infusion was 
discontinued, one (1) gram of intravenous acetaminophen was given, and a cooling blanket 
was applied;  the fever subsequently decreased with complete resolution to normal baseline 
at six hours. 
 
  
 
 
DISCUSSION 
 
Dexmedetomidine’s primary site of action is the Locus Coeruleus,  the major 
noradrenergic nucleus of the brain that communicates with a wide subset of neural 
structures and plays a central role in a number of physiologic functions.1  The primary 
effect of dexmedetomidine on the Locus Coeruleus is regulation of arousal, making it a 
common choice for sedation in the ICU.  Recently, however, it has been found to play a 
role in the control of autonomic function1 with the rare side effect of pyrexia.  Nuclei in the 
Caudal Raphe Magnus are involved in thermoregulation, causing increases in body 
temperature secondary to direct stimulation from the Locus Coeruleus.1  
Dexmedetomidine has been implicated in a small but growing number of case reports of 
drug-induced fever as a rare side effect.2  In our case, after starting dexmedetomidine 
according to our institutional standards and established critical care guidelines3, an 
extreme fever was noted;  dexmedetomidine was immediately suspect due to the timing of 
the fever and lack of other readily identifiable causes, therefore it was immediately 
discontinued and the fever treated.  
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DISCUSSION 
 
Anesthetic management of a patient with an active parasitic 
infection in the setting of obstructing hydrocephalus can be 
quite challenging. This patient presented with symptoms of 
increased intracranial pressure as well as systemic signs and 
symptoms of active infection requiring an urgent posterior 
fossa craniotomy.  The patient underwent close neuro-
monitoring throughout the case and was intubated using a 
glidescope to ensure appropriate placement of a NIM EMG 
monitoring endotracheal tube. The patient was maintained on 
remifentanil,  PrecedexTM and propofol infusions; paralysis 
was avoided to ensure that appropriate motor monitoring 
could be achieved. Intraoperatively, the patient was given 
anti-seizure prophylaxis as well as agents to decrease 
cerebral edema.  Close arterial monitoring was achieved by 
utilizing an arterial line. Two large bore intravenous catheters 
were placed following induction. The neurosurgeon entered 
the third and fourth ventricles, where hundreds of cysts were 
identified and removed.  Postoperatively, the patient was 
transferred , intubated, to the surgical intensive care unit for 
hourly neurochecks. Interestingly, the clinical presentation 
typically associated with neurocysticercosis is one of later 
progression of the infection and adult onset seizures. 2,4  This 
patient presented with what appeared to be an active 
parasitic infection and the most immediate symptoms 
requiring urgent surgical intervention were associated with 
obstruction and an acute iatrogenic inflammatory response 
related to the anti-helminthic regimen.  
Unfortunately, the patient’s clinical course was complicated 
by continued episodes of obstructive symptoms requiring 
multiple surgical re-explorations and placement of a lumbar 
drain, which was further complicated by Klebsiella meningitis. 
Although the patient initially showed signs of improvement 
and was discharged three months after his first admission, he 
was quickly readmitted and succumbed six months after 
initial presentation. 
 
INTRODUCTION 
 
 
Cysticercosis infection is associated with the larval 
stage of the tapeworm Taenia Solium. It is most 
commonly found in the developing world, is associated 
with the ingestion of T. Solium eggs shed in the stool of 
a human tapeworm carrier, and is often identified as the 
cause of adult onset seizure disorders.1,2  Associated 
clinical syndromes are neurocysticercosis and 
extraneural cysticercosis.  Neurocysticercosis 
specifically describes a parasitic infection of the central 
nervous system caused by migration of larval cysts 
from the gastrointestinal tract into the vascular and, 
ultimately, the central nervous systems.3  
Neurocysticercosis is further classified as parenchymal 
and extraparenchymal, with extraparenchymal 
neurocysticercosis specifically involving intraventricular, 
subarachnoid, spinal or ocular involvement.  
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CASE DESCRIPTION 
 
 
A 59-year-old Nigerian male was transferred to our 
institution following initial workup at an outside hospital 
for acute onset gate changes, general malaise and 
urinary incontinence.  Imaging at the sending hospital 
was concerning for parasitic infection given patient’s 
clinical findings and recent immigration from Nigeria.  
Further imaging at Baystate was most concerning for 
obstructing hydrocephalus from cystic lesions in the 
third and fourth ventricles. Initial medical management 
focused on an anti-helminthic regimen and hourly 
neuro-monitoring in the intensive care unit. As the 
patient’s clinical picture waxed and waned, the decision 
was made to proceed with surgical decompression of 
the obstructing lesion via a posterior fossa craniotomy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  Figure 2.  Close-up of T. Solium Cysts removed from  
  patient.  Photo by author.    
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Figure 1.  T. Solium Cysts being removed from  
  patient. Photo by author.   
CONCLUSION 
Genicular RFA is an effective pain management alternative for patients with chronic knee 
pain refractory to pharmacologic and/or surgical intervention. While there is a lack of 
literature with head-to head comparison of the specific RFA modalities, there are strong 
evidences that radioablation of the genicular nerves can alleviate knee pain and improve 
daily function. 
CASE DESCRIPTION 
 
 
A 61 year old female with a history of Polio 
suffers from intractable left knee pain due to 
severe joint space narrowing secondary to 
her leg deformity. She failed conservative 
treatments including physical therapy, 
analgesic medications, repeated intra-
articular injections of steroid and visco-
supplementation. Total knee replacement 
was not recommended due to her gross 
deformity.  
 
She presented for left genicular nerve cooled 
radiofrequency ablation under fluoroscopy 
guidance after successful diagnostic 
genicular nerve block with Bupivacaine 3 ml 
of 0.5%. Fluoroscopy (in anterior posterior 
and lateral views) was used to identify needle 
(17G, 100mm) placement at the 
superomedial, lateral, and inferomedial 
genicular nerves of the affected  knee joint.  
 
Lidocaine 2% 1 ml and Bupivacaine 0.25% 2 
ml were injected to each site prior to cooled 
radiofrequency at 60ͦ C for 2.5 minutes. 
Patient denies any paresthesia during 
procedure and tolerated procedure 
uneventfully. 
 
On follow-up visit, patient reported more than 
90% pain relief and relief lasting more than 8 
weeks with improvement of daily activities 
such as ambulation, cooking, and cleaning.  
INTRODUCTION 
 
Radiofrequency ablation (RFA) has been 
used to treat a variety of pain conditions such 
as trigeminal neuralgia, cervicogenic 
headaches, and spinal pain.  
 
In recent years, RFA procedures provided an 
alternative pain management for patients with 
chronic knee pain. This patient population 
often are refractory to conventional medical 
treatment, had failed surgical intervention, or 
are  non-surgical candidates. 
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Conventional  RFA Pulsed  RFA Cooled  RFA 
Mechanism • Electrode tip (electromagnetic field 
frequency of 250kHz) heats  
targeted local tissue within a few 
millimeters to 47°C for 2 minutes. 
• Pulse generator producing pulses 
amplitude of 45V lasting 20ms every 
500ms (twice per second). 
• RFA perform at 40-67°C with tissue 
temperature reaches maximum 42°C 
• Thermal ablative mechanism: water 
circulates inside the probe removing 
heat, which modulates the thermal 
heat (60°C), and alters the size, shape, 
and projection of lesions.  
Pros/Cons • Heat generation resulting in 
thermocoagulation and localized 
neuronal tissue destruction  
• Ablative heat promote 
neuromodulation by inhibition of 
excitatory C-fibers 
• Less neuro-destructive 
• Patients experience less pain with 
procedure 
• Less risk for development 
deafferentation pain 
• Shorter duration of pain relief 
• Requires more frequent procedure 
performed to achieve similar level of 
pain relief. 
• Greater CRF lesion reduces the 
number of technical failures when 
addressing complex and variable 
neuronal innervation of the knee 
• Ability to target greater amount of 
neuronal tissue producing longer 
duration of pain relief 
Table 1: Types of Radiofrequency Ablation Therapeutic Technologies1 
Figure 1. Genicular Nerves Anatomy 
(Medial View) Medial view of the 
knee demonstrating the relative 
location of the superior medial 
genicular nerve and the inferior and 
medial genicular nerve and their 
corresponding articular arteries. 
Figure 1. Obtained  from  Clinical  
Key Figure 134-45.  
Figure 2: Genicular Nerves Anatomy 
(Lateral View) Lateral view of the 
knee demonstrating the relative 
location of the superior lateral 
genicular nerve and the inferior 
lateral genicular nerve and their 
corresponding  articular  arteries. 
Figure 2. Obtained  from  Clinical  
Key Figure 134-55 
Image of patient  taken with  permission  Baystate Medical  Center  
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Figure 3. Genicular Nerve Block Needle 
Placement AP View. Fluoroscopic image 
taken from patient chart at Baystate 
Medical Center    
Figure 4. Genicular Nerve Block Needle 
Placement Lateral View. Fluoroscopic 
image  taken  from  patient at Baystate 
Medical Center  
DISCUSSION  
 
Radiofrequency ablation at 40-70°C causes protein denaturation and coagulation necrosis at 
targeted nerve site. RFA is believed to  stop nociceptive (A- δ and C-fibers) pain inputs 
without destroying the motor or sensory (A-β) fibers.1-3 It has been shown that the Schwann 
cells may be preserved after RFA, which would allow nerve regeneration. Based on available 
evidences, RFA of genicular nerves can provide on average more than 60% pain relief for 3 
to 6 months.1                                                                                                                                                                                                                                         
Current RFA modalities being used for chronic knee pain are Conventional RFA, Pulsed RFA, 
and Cooled RFA. Though literature regarding the efficacy of RFA is limited there is strong 
evidence that supports RFA in treating chronic knee pain especially in patients with pain from 
osteoarthritis and/or post-total knee arthroplasty. Due to different study methodologies and 
inconsistent patient assessment measures, there is a low level of certainty that one type of 
RFA procedure is more superior to the other in their benefit and safety profile. 
 
A complex network of articular nerves from the tibial, common peroneal, femoral, and 
obturator supply the knee joint. Tributaries from these nerves form the RFA targeted genicular 
nerves (superior lateral, superior medial, and inferior medial).2,4 The inferior lateral nerve is 
not targeted due to its proximity to the common peroneal nerve, which can result in foot drop. 
As arteries travel with nerves, ablating nerves using bony landmark may lead to undesired 
vascular complication. Genicular artery injuries, though uncommon, can carry significant 
morbidities. Most often, these vascular injuries result in formation of pseudoaneurysm, AV 
fistula, hemarthrosis, and/or necrosis of the patella.2 Injury to the neighboring saphenous 
nerve should also be considered when performing RFA  on medial knee nerves. 
 
Physical exam landmarks, fluoroscopy, ultrasonography, or a combination is used during 
procedures to determine anatomical structures. Currently, an open study by Mata J. et al 
postulates that the use of ultrasound-guided (US) genicular block has more advantages over 
fluoroscopically guided techniques. US provides visualization of neurovascular bundles and 
nerve identification. Also, US-guided approaches are less expensive, easily reproduced, and 
are without exposure to radiation.3 While studies that utilize visualization guidance tend to 
have positive outcomes, there is no current data to support the superiority of one imaging 
modality over another or that RFA procedures necessitates imaging. 
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Introduction 
 
Perioperative pain management in chronic pain patients can 
present a challenge, especially if they are treated with long term 
opioids. This case describes the use of multimodal analgesia 
perioperatively in an opioid-dependent chronic pain patient.  
 
 
Case Description 
 
A 57-year-old male with a history of chronic pain and long term 
daily opioid use presented for a sternal hardware removal, open 
reduction and internal fixation and cadaveric bone graft for a 
nonunion of prior sternotomy. A multimodal approach was used for 
perioperative pain management with a combination of medications 
to address multiple different pain receptors and pathways. Patient 
received high dose fentanyl, dexmedetomidine, ketamine, 
intravenous acetaminophen, and continuous intercostal nerve 
blockade with local anesthetics via surgically placed On-Q pump. 
The perioperative course was uneventful and patient was 
comfortable in the postoperative period. 
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Medication/Technique Description  
Regional Anesthesia Neuraxial block or peripheral nerve block 
Acetaminophen  Inhibits the synthesis of prostaglandins 
Non-steroidal anti-inflammatory drugs 
Non-selective: Inhibits cyclooxygenase 1 
and cyclooxygenase 2 (Ex: Ketorolac) 
 
Selective: Inhibits cyclooxygenase 2 only 
(Ex: Celecoxib) 
Opiates  
Acts on mu receptors which are primarily 
located in substantial gelatinosa of the 
spinal cord and periaqueductal gray 
matter in the brain 
Gabapentin and Pregabalin  
GABA B (1a,2) receptor subtype-selective 
agonist, and activates postsynaptic K 
channels and inhibits postsynaptic 
calcium channels 
Intravenous Lidocaine (2) 
Sodium channel blocker 
Inhibition of priming of 
polymorphonuclear granulocytes 
Inhibition of intracellular G protein 
signaling molecules. 
Alpha 2 agonists  
(Dexmedetomidine, clonidine) 
Presynaptic alpha 2 receptor agonist and 
decreases the release of norepinephrine. 
Alpha receptors are rich at locus 
coeruleus, pons. 
 
 
Ketamine 
Non-competitive antagonist of NMDA 
receptor calcium channel and a weak 
opiate receptor agonist.  
Magnesium Inhibits calcium influx into the cell and antagonist of NMDA receptors.  
  
Discussion  
 
Chronic pain is a complex disease that can lead to dysregulation of 
one or more of the pain receptors within the pain pathway.3,4  These 
changes can cause increased spontaneous activity as well as 
hyperresponsiveness to noxious and non-noxious stimuli.3  Pain 
management in these patients can be a challenge and may lead to 
inadequate pain control. Multimodal analgesia can be useful in 
managing patient pain by addressing multiple receptors involved in 
the pain pathway.4  
 
In addition, the use of pre-emptive analgesia by administering 
medication prior to incision to cause an imitation of the activation of 
the nociceptive pathways and central sensitization can be useful in 
managing pain in opioid-dependent chronic pain patients. However, 
at this time, clinical data does not show a benefit of preemptive 
analgesia compared to post-incisional administration of analgesic 
medications.5  
Conclusion  
 
The patient's perioperative pain was effectively managed with 
opiates, dexmedetomidine, ketamine, intravenous 
acetaminophen and continuous intercostal block. The use of 
multimodal analgesia is a way to provide pain management in 
a chronic pain patient. Multimodal Mechanism of Pain
1 
 
• Peripheral pain receptors: Sensitive to capsaicin, moderate 
thermal stimuli, acid pH, adenosine, and other related 
phosphates  
• Ion channels: Voltage-gated sodium channels, voltage-gated 
calcium channels 
• Inflammatory Mediators: Substance P, bradykinin, cytokines, 
prostaglandins 
• Peripheral sensitization  
• Central sensitization  
 
 
Multimodal Approach to Pain Management in an 
opioid-dependent chronic pain patient  
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INTRODUCTION 
 
The field of thoracic surgery is evolving and the invention 
of video-assisted thoracic surgery (VATS) has changed the 
way surgeons treat thoracic diseases by focusing on a 
minimally invasive approach. Similarly, less conventional 
thoracic anesthesia strategies have evolved to encompass 
less invasive surgical techniques and enhance fast track 
perioperative pathways.1 The term non-intubated VATS 
refers to thoracic operations that are performed without 
general anesthesia and mechanical ventilation in 
spontaneously breathing subjects.2 Research through the 
years has shown that non-intubated VATS is a safe and 
feasible technique for thoracic surgery.  
 
DISCUSSION 
 
Non-intubated VATS has been extensively promoted and proven safe for 
treatment of pleural effusion, empyema, bullous emphysema, 
spontaneous pneumothorax, biopsy of interstitial lung disease, wedge 
resection of lung nodules, lobectomies, mediastinal biopsy and tumor 
excision.3 
  
The main advantage of non-intubated thoracic surgery is to avoid the 
perioperative morbidity associated with the deleterious effects of general 
anesthesia and one lung ventilation. These include airway pressure 
induced injury, atelectasis, hypoxemia, ventilation/perfusion mismatch, 
throat pain, laryngeal/tracheal injuries, cognitive dysfunction, residual 
neuromuscular blockade, etc.  
 
Non-intubated patients have been shown to have shorter total operating 
time, shorter duration of pleural fluid leakage, decreased postoperative 
hospital stay, lower postoperative morbidity and mortality, lower cost, 
earlier postoperative improvement in physical function and decreased 
mental confusion.5 
CASE DESCRIPTION 
 
A 76-year-old man with COPD, emphysema, and left 
recurrent pneumothorax presented with dyspnea and large 
basilar loculated left spontaneous pneumothorax. Despite 
initial chest tube placement, the pneumothorax persisted. 
He underwent a video-assisted thoracoscopic mechanical 
pleurodesis and larger bore thoracostomy tube placement. 
The procedure was performed under monitored anesthesia 
care with dexmedetomidine, propofol, and remifentanil 
infusions. Patient remained sedated and comfortable 
throughout surgery. Preinduction oxygen saturation was 
88% and during the case the patient maintained 
spontaneous ventilation with oxygen saturations of 99% on 
15 liters via facemask. He tolerated the procedure well and 
transferred to the recovery room in satisfactory condition. 
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CONCLUSION 
 
For non-intubated VATS to be successful, minimizing pain and stress along 
with effortless spontaneous ventilation needs to be achieved. Anesthetic 
options include sedation with Propofol, remifentanil, benzodiazepines, and 
dexmedetomidine infusions, thoracic epidural anesthesia, thoracic 
paravertebral block, intercostal nerve block, and local infiltration. To prevent 
coughing during the procedure, lidocaine inhalation, stellate ganglion block or 
a vagal nerve block can be performed to inhibit cough reflex.3 Now that 
feasible, reliable, and safer anesthetic modalities exist as an alternative to 
general anesthesia and one lung ventilation for VATS, the non-intubated 
approach is becoming more utilized in practice.  
PATHOPHYSIOLOGY 
 
For non-intubated VATS to be successful, a thorough understanding of the 
underlying mechanisms of spontaneous ventilation during lung surgery is 
important. 
 The match of ventilation and perfusion is better maintained in the 
dependent lung during spontaneous ventilation  
 In the anesthetized patient, the non-dependent lung receives zero 
ventilation and perfusion decreases due to hypoxic pulmonary 
vasoconstriction. In non- intubated patients, perfusion to the dependent 
ventilated lung is better because of low/negative pressure in the lung.  
Intrapulmonary shunt and hypoxemia is reduced and lung recruitment is 
increased maintaining diaphragmatic function.  
 During a non-intubated approach, there is a risk of experiencing carbon 
dioxide rebreathing effect however it is rare to need ventilatory support.4 
 
Fig. 1.  Radiographic image of a 
patient with a left spontaneous 
pneumothorax  
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Fig. 2.  Video assisted thoracoscopic 
surgery (VATS) showing blebs in patient 
with spontaneous pneumothorax  
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